NCT02545556
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Liver Cancer, +4 more
- Locations
-
- Central laboratory in Fuda cancer hospital Guangzhou, Guangdong, China
Clinical trial condition
Liver Diseases
Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.
8,418 public trials
1,316 recruiting studies
Liver Diseases trial results
NCT01358864
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- 1220.7.0091 Boehringer Ingelheim Investigational Site North Little Rock, Arkansas, United States
- 1220.7.0082 Boehringer Ingelheim Investigational Site Englewood, Colorado, United States
- 1220.7.0095 Boehringer Ingelheim Investigational Site Palm Harbor, Florida, United States
- 1220.7.0039 Boehringer Ingelheim Investigational Site Columbus, Georgia, United States
NCT02880306
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
Not specified
NCT02753699
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Novartis Investigative Site La Jolla, California, United States
- Novartis Investigative Site San Diego, California, United States
- Novartis Investigative Site Ventura, California, United States
- Novartis Investigative Site Bradenton, Florida, United States
NCT01277601
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- Asian Pacific Liver Center Los Angeles, California, United States
- Stanford University Medical Center Palo Alto, California, United States
- Research and Education Inc San Diego, California, United States
- San Jose Gastroenterology San Jose, California, United States
NCT02877199
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +11 more
- Locations
-
- Hôpital de la Croix Rousse Lyon, France
NCT02732639
- Conditions
- Chronic Disease, Digestive System Diseases, Disease Attributes, +11 more
- Locations
-
- Bucharest, Romania
- Bucharest, Romania
- Cluj-Napoca, Romania
- Constanța, Romania
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Novartis Investigative Site San Diego, California, United States
- Novartis Investigative Site San Diego, California, United States
- Novartis Investigative Site Ventura, California, United States
- Novartis Investigative Site Bradenton, Florida, United States
NCT01575574
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Hospital Clinic of Barcelona Barcelona, Spain
Completed
Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma
NCT01777594
- Conditions
- Adenocarcinoma, Advanced Adult Hepatocellular Carcinoma, Carcinoma, +9 more
- Locations
-
- Mary Crowley Cancer Research Center Dallas, Texas, United States
- Oncology Consultants, PA Houston, Texas, United States
- University of Texas Health Sciences Center at Houston, Memorial Hermann Cancer Center Houston, Texas, United States
- The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States